DLCIG
D.L. Carlson Investment Group’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-2,190
| Closed | -$256K | – | 131 |
|
|
2022
Q3 | $256K | Hold |
2,190
| – | – | 0.06% | 117 |
|
|
2022
Q2 | $258K | Hold |
2,190
| – | – | 0.05% | 119 |
|
|
2022
Q1 | $285K | Hold |
2,190
| – | – | 0.05% | 124 |
|
|
2021
Q4 | $334K | Buy |
+2,190
| New | +$334K | 0.05% | 116 |
|
|
2019
Q1 | – | Sell |
-3,487
| Closed | -$336K | – | 149 |
|
|
2018
Q4 | $336K | Buy |
+3,487
| New | +$336K | 0.11% | 117 |
|
|
2018
Q3 | – | Sell |
-31,090
| Closed | -$3.41M | – | 141 |
|
|
2018
Q2 | $3.41M | Sell |
31,090
-5,155
| -14% | -$566K | 1.04% | 42 |
|
|
2018
Q1 | $3.87M | Sell |
36,245
-4,495
| -11% | -$480K | 1.22% | 35 |
|
|
2017
Q4 | $4.35M | Buy |
40,740
+27,182
| +200% | +$2.9M | 1.29% | 25 |
|
|
2017
Q3 | $4.52M | Buy |
13,558
+1,951
| +17% | +$651K | 1.4% | 25 |
|
|
2017
Q2 | $3.6M | Buy |
11,607
+2,731
| +31% | +$847K | 1.06% | 37 |
|
|
2017
Q1 | $2.6M | Buy |
8,876
+90
| +1% | +$26.4K | 0.88% | 49 |
|
|
2016
Q4 | $2.33M | Buy |
8,786
+85
| +1% | +$22.6K | 0.79% | 59 |
|
|
2016
Q3 | $2.52M | Buy |
8,701
+912
| +12% | +$264K | 0.88% | 59 |
|
|
2016
Q2 | $2M | Buy |
7,789
+3,062
| +65% | +$788K | 0.72% | 62 |
|
|
2016
Q1 | $1.23M | Sell |
4,727
-3
| -0.1% | -$783 | 0.46% | 79 |
|
|
2015
Q4 | $1.6M | Buy |
+4,730
| New | +$1.6M | 0.6% | 68 |
|
|
2014
Q2 | – | Sell |
-2,475
| Closed | -$585K | – | 132 |
|
|
2014
Q1 | $585K | Sell |
2,475
-13,831
| -85% | -$3.27M | 0.22% | 101 |
|
|
2013
Q4 | $3.7M | Sell |
16,306
-2,430
| -13% | -$552K | 1.35% | 28 |
|
|
2013
Q3 | $3.93M | Buy |
18,736
+3,981
| +27% | +$834K | 1.51% | 21 |
|
|
2013
Q2 | $2.57M | Buy |
+14,755
| New | +$2.57M | 1.03% | 42 |
|